000006554 000__ 01165cam\a22003375i\4500
000006554 001__ 6554
000006554 003__ SzGeWIPO
000006554 005__ 20240708160719.0
000006554 008__ 941126s1994\\\\enk\\\\\r\\\\u000\0\eng\d
000006554 035__ $$a(wipo)(CD )$36122
000006554 035__ $$a(OCoLC)1158916249
000006554 040__ $$aSzGeWIPO$$beng$$erda$$cSzGeWIPO$$dCaBNVSL
000006554 084__ $$a72$$qGB
000006554 1001_ $$aMarks, David,$$eauthor.
000006554 24510 $$aLife beyond the patent /$$cDavid Marks.
000006554 264_1 $$aLondon [England] :$$bEuromoney Institutional Investor PLC,$$c1994.
000006554 300__ $$a1 volume ([6] pages) ;$$c[28] cm.
000006554 336__ $$atext$$btxt$$2rdacontent
000006554 337__ $$aunmediated$$bn$$2rdamedia
000006554 338__ $$avolume$$bnc$$2rdacarrier
000006554 4901_ $$aManaging Intellectual Property ;$$v1994 No 36 pages 13-19
000006554 650_0 $$aPatents.
000006554 650_0 $$aIntellectual property.
000006554 650_4 $$aPATENTS : PHARMACEUTICAL PRODUCTS
000006554 650_4 $$aPATENT TERM EXTENSION : BRANDED DRUGS
000006554 650_4 $$aMARKETING EXCLUSIVITY
000006554 830_0 $$aManaging Intellectual Property ;$$v1994 No 36 pages 13-19.
000006554 903__ $$v1$$aMANAGING INTELLECTUAL PROPERTY
000006554 904__ $$aJournal article
000006554 942__ $$cART$$2ddc
000006554 952__ $$w2006-11-03$$p1994-36122$$r0.00$$u6889$$bMAIN$$10$$k GB 72$$v1994-11-26$$zLibrary$$70
000006554 980__ $$aBIB
000006554 999__ $$c6816$$d6816